Multi-Perspective Quality Control of Illumina RNA Sequencing Data Analysis

RNA sequencing (RNA-seq) is a powerful tool for analyzing the transcriptome, offering insights into gene expression, splicing, and non-coding RNA functions. With wide applications in fields such as disease mechanisms, cancer genomics, and drug discovery, RNA-seq plays a crucial role in advancing research.

However, the reliability and reproducibility of RNA-seq results are contingent upon proper quality control (QC) at every stage of the process. Issues such as contamination, degradation, or misalignment can severely compromise the data if QC is not thoroughly implemented, leading to biased or incomplete results.

Research shows that, despite its importance, RNA-seq QC is often overlooked or inadequately performed. In fact, 63% of publicly available sequencing data from clinical samples fail to meet quality standards, compromising reproducibility and the reliability of published results.

This underscores the need for a multi-perspective QC approach that assesses RNA-seq data at multiple stages, ensuring that quality is maintained throughout the pipeline.

This article examines how inadequate QC can negatively impact RNA-seq data, focusing on contamination sources and their downstream effects on data integrity. It also explores how a multi-perspective QC strategy addresses these issues, ensuring reliable data and more accurate biological insights.

Stages of RNA-seq Quality Control

Quality control in RNA sequencing is a multi-step process that ensures the integrity and accuracy of the data at every stage, from sample preparation to final analysis. Each stage is critical to prevent errors that could compromise the reliability of the results.

The four key stages of RNA-seq quality control are RNA quality, raw read data assessment, alignment to the reference genome, and gene expression analysis.

Let’s explore these stages in detail, starting with the importance of RNA quality in the sequencing process.

Stage 1: RNA Quality

The first and most crucial step in RNA sequencing (RNA-seq) is ensuring that the RNA sample is of high quality. The integrity of RNA directly influences the reliability of sequencing results.

Degraded RNA can lead to incomplete or biased data, particularly when studying low-abundance transcripts or more fragile RNA species. For RNA-seq to be accurate, RNA samples must be intact and free of contaminants.

RNA Integrity Number (RIN) is the most widely used metric to assess RNA quality. RIN scores range from 1 (degraded) to 10 (intact). A high RIN score, typically above 7, is required for obtaining reliable sequencing data.

Samples with lower RIN scores may yield unreliable results, especially when analyzing complex transcriptomes or less abundant RNA species. Studies have shown that samples with RIN scores below 7 can significantly compromise the accuracy of RNA-seq analyses, especially in the case of differential gene expression analysis.

QC tools to check RNA Quality:

Bioanalyzer: The Bioanalyzer is a widely used tool for assessing RNA integrity. It provides high-resolution electropherograms that display RNA degradation patterns. By analyzing the distribution of ribosomal RNA (rRNA) peaks, the Bioanalyzer can determine the quality of the RNA sample and whether it is suitable for RNA-seq.
Agilent TapeStation: Similar to the Bioanalyzer, the Agilent TapeStation is another tool used for evaluating RNA quality. It generates electropherograms that show the size distribution of RNA fragments, helping to visualize degradation levels. This tool is essential for confirming RNA integrity by assessing the size and shape of RNA profiles, ensuring the sample’s suitability for sequencing.

These instruments provide high-resolution electropherograms that visualize RNA degradation. Assessing the distribution of ribosomal RNA (rRNA) peaks and examining the size and shape of the RNA profiles help determine the extent of degradation and whether the sample is suitable for RNA-seq.

When RNA integrity is poor, it can severely impact downstream processes such as library construction and gene expression quantification. Degraded RNA results in inefficient cDNA synthesis, leading to incomplete transcriptome representation.

This is especially problematic when analyzing low-abundance RNA species, like long non-coding RNAs (lncRNAs), which are more susceptible to degradation. As a result, poor RNA quality can cause underrepresentation or complete omission of these transcripts, ultimately distorting the sequencing data.

In one study, poor RNA quality, indicated by a low RIN, was found to reduce the detection sensitivity of low-abundance transcripts like lncRNAs, further emphasizing the need for proper RNA quality assessment before sequencing.

Ensuring RNA quality is just the first step in the RNA-seq process. Once RNA integrity is confirmed, the next critical step is assessing the raw sequencing data to ensure its accuracy and readiness for downstream analysis. Let’s explore how raw read data is evaluated in the next stage.

Stage 2: Assessment of Raw Sequencing Data (FASTQ Files)

After RNA sequencing, the resulting raw data is stored in FASTQ files, which include both the nucleotide sequences and their associated quality scores. Evaluating these quality scores is essential to ensure the reliability of subsequent analyses.

Key Quality Metrics to Evaluate:

Base Quality Scores: These scores indicate the confidence in each base call. Higher scores (typically above Q30) reflect greater accuracy, while lower scores may suggest sequencing errors. Inconsistent quality scores across reads can signal issues with the sequencing process.
GC Content: The proportion of guanine (G) and cytosine (C) nucleotides within the sequences. Anomalies in GC content distribution can point to biases introduced during library preparation or sequencing, which may affect downstream analyses.
Read Length Distribution: It is crucial to ensure that the majority of reads conform to the expected length. Deviations can arise from sequencing artifacts or issues during library construction, potentially impacting alignment and mapping efficiency.
Sequencing Depth: Refers to the number of times a nucleotide is read during sequencing. Adequate depth is vital for accurate variant detection and gene expression analysis. Insufficient depth may lead to missed variants or unreliable expression measurements.

Common QC Issues in FASTQ Files

Several common issues can arise in FASTQ files that can compromise data quality, including the following:

Adapter Contamination: Residual adapter sequences from the sequencing process can contaminate reads, leading to misalignment and erroneous results.
Excessive GC Content: Abnormal GC content can indicate biases introduced during library preparation, affecting the representation of certain genomic regions.
Low Base Quality: Reads with consistently low-quality scores can result from sequencing errors, which, if not properly addressed, can lead to unreliable data.

Carefully inspecting FASTQ files can identify these common issues early in the process, allowing researchers to address them before proceeding to alignment and gene expression analysis.

QC Tools for Raw Data Assessment:

FastQC: A widely used tool that provides a comprehensive analysis of raw sequencing data. It generates reports on various quality metrics, including base quality scores, GC content, and potential contaminations.

FastQC is compatible with multiple file formats, such as FASTQ, BAM, and SAM, and is user-friendly, making it accessible for both novice and experienced users.

MultiQC: Designed to aggregate results from multiple QC tools like FastQC, MultiQC offers a consolidated overview of quality metrics across various samples. This aggregation aids in identifying systematic issues and facilitates the comparison of quality metrics between different datasets.

Researchers can identify and address potential issues in raw sequencing data by systematically assessing these quality metrics and utilizing tools like FastQC and MultiQC, ensuring the reliability of subsequent analyses.

Now that the raw sequencing data has been assessed and quality issues identified, the next critical step is aligning the reads to the reference genome.

Stage 3: Alignment

Aligning RNA-seq reads to a reference genome, or transcriptome is a fundamental step in RNA sequencing (RNA-seq) data analysis. This process allows researchers to map RNA-seq reads to specific genes, facilitating the accurate quantification of gene expression levels.

Correct alignment is essential for subsequent downstream analyses, such as differential expression analysis, alternative splicing, and transcriptomic profiling. A high-quality alignment ensures that reads are assigned to the correct genomic locations, ultimately enabling more accurate interpretations of biological processes.

Accurate alignment depends on the choice of the reference genome (or transcriptome) and the alignment tool used. Misalignment can lead to significant errors in gene expression quantification, potentially leading to false conclusions about gene activity and regulatory mechanisms.

Key Alignment Tools

Several alignment tools are commonly used in RNA-seq, depending on the complexity of the genome, sequencing goals, and the presence of spliced reads.

Here are some of the most widely used tools:

STAR (Spliced Transcripts Alignment to a Reference): STAR is a fast and highly efficient aligner, especially suited for mapping spliced RNA-seq reads. It is particularly advantageous when working with large datasets and complex genomes, as it handles spliced alignments well, allowing for more accurate detection of exon-exon junctions. STAR is one of the most popular aligners due to its speed and accuracy in handling large-scale RNA-seq data.
HISAT2: HISAT2 is another widely used aligner known for its efficiency and ability to align reads to large, complex genomes. It is particularly suitable for human genome mapping and other high-complexity genomes. HISAT2 uses an advanced indexing technique that allows for faster alignments compared to older tools.
TopHat: Though somewhat older, TopHat is still employed for aligning RNA-seq reads, particularly when spliced alignment is required. While newer tools like STAR and HISAT2 are often preferred for their speed and accuracy, TopHat remains a useful option in certain situations where specific alignments are needed.

MAPQ Distribution

MAPQ (Mapping Quality) scores provide a measure of confidence in each read’s alignment. A higher MAPQ score indicates a more confident alignment, meaning the read is more likely to be accurately mapped to the correct genomic location.

Conversely, lower MAPQ scores suggest possible misalignments, indicating that the read may have been incorrectly assigned or mapped to a region with low confidence.

Monitoring MAPQ distribution across the dataset is essential for ensuring that the reads are reliably mapped to the reference genome. This helps identify potential alignment issues that could compromise downstream analyses like gene expression quantification and variant calling.

Resolving Misalignment Issues

Misalignments in RNA-seq data can arise from various factors, including inaccuracies in the reference genome, sequencing errors, or the presence of complex genomic regions such as repetitive sequences or novel splice junctions. Addressing these misalignments is crucial for accurate downstream analyses.

Parameter Adjustment: Fine-tuning alignment parameters—such as mismatch penalties, gap penalties, and read length thresholds—can enhance mapping accuracy by reducing misalignments.

Re-alignment: Employing different alignment tools or utilizing an updated reference genome can resolve persistent misalignments. For instance, recalibrating mapping quality (MAPQ) scores has been shown to improve variant calling performance in low-coverage sequencing data.

A study demonstrated that recalibrating MAPQ scores led to a 5.2% increase in recall for single nucleotide polymorphism (SNP) detection in rice, with precision remaining high at 0.91 to 0.95.

By systematically addressing misalignment issues through these strategies, researchers can ensure that RNA-seq data is accurately mapped, thereby providing a reliable foundation for gene expression analysis and subsequent functional genomics studies.

With the reads properly aligned to the reference genome, the next critical step is to analyze gene expression levels and identify potential biases or confounding factors.

Stage 4: Gene Expression

Quantifying gene expression is a key objective of RNA sequencing (RNA-seq), providing critical insights into transcriptional activity. However, various biases, such as batch effects, library preparation biases, and incorrect normalization, can influence the accuracy of gene expression measurements.

These biases can distort gene expression levels, making it essential to address them before drawing biological conclusions.

Rigorous quality control (QC) is essential at every stage to ensure RNA-seq results reflect true biological variation rather than technical artifacts. Without proper QC, downstream analyses such as differential expression, pathway analysis, and biomarker discovery can lead to misleading results, highlighting the importance of adequate quality control.

Metrics for Gene Expression Quantification

Several metrics are commonly used to quantify gene expression:

Transcripts Per Million (TPM): This metric normalizes gene expression by accounting for both sequencing depth and gene length, making it suitable for comparing gene expression across samples. TPM is commonly used in many RNA-seq applications.
Fragments Per Kilobase of transcript per Million mapped reads (FPKM): FPKM normalizes for both sequencing depth and gene length, though it has limitations when comparing gene expression across different samples. FPKM is more useful for within-sample comparisons.
Raw Counts: Raw counts represent the number of reads mapped to a specific gene and are essential for differential expression analysis. However, they need to be normalized for sequencing depth and gene length before comparing samples.

The choice of which metric to use depends on the experimental design, goals, and whether comparisons are being made within or between samples.

Normalization Methods

Normalization is an essential step in RNA-seq data analysis to adjust for biases like sequencing depth, gene length, and library composition. Correct normalization ensures that differences in gene expression across samples are due to biological variation, not technical discrepancies.

DESeq2: This tool is commonly used for differential gene expression analysis and normalization of RNA-seq data. DESeq2 uses a negative binomial model to estimate variance and differential expression while normalizing for sequencing depth.
edgeR: Like DESeq2, edgeR uses a generalized linear model (GLM) approach for differential expression analysis and normalization of raw counts. It is effective for small sample sizes and also adjusts for sequencing depth and library size.

Both DESeq2 and edgeR are vital for ensuring unbiased comparisons of gene expression across experimental conditions.

Clustering and Principal Component Analysis (PCA) as QC Measures

To evaluate the integrity of RNA-seq data, PCA and clustering are used as quality control measures:

Principal Component Analysis (PCA): PCA reduces the dimensionality of gene expression data, allowing for the visualization of patterns and relationships between samples. It helps identify outliers and potential batch effects, making it a critical tool for quality assessment.
Hierarchical Clustering: This technique groups samples based on gene expression similarity, helping to identify outliers and detect any technical inconsistencies in the data. By examining the clustering of biological replicates, researchers can assess data quality.

Both PCA and clustering are valuable for confirming that gene expression data is consistent and free from technical artifacts.

Addressing Biases in Gene Expression Analysis

Beyond technical biases, biological factors like cell-type heterogeneity or gene length variability can also affect gene expression measurements. Advanced normalization techniques help mitigate these biases and enhance the accuracy of expression analysis.

For example, methods such as quantile normalization or TMM (Trimmed Mean of M-values) can be applied to handle biases in gene length and sequencing depth.

Gene expression analysis is critical in RNA-seq, but the data quality can vary depending on the RNA type used. Different RNA-seq applications—such as mRNA-seq, total RNA-seq, and small RNA-seq—pose unique challenges. Let’s explore the specific quality issues in each type and how to address them for reliable results.

Quality Issues in Different Types of RNA-seq

Different types of RNA-seq—mRNA-seq, total RNA-seq, and small RNA-seq—have unique features and associated challenges that can affect the overall quality of the data. Understanding these challenges is crucial for ensuring that the data is accurate and reproducible.

The table below summarizes the key differences and challenges of each RNA-seq type.

RNA-seq Type	Key Features	Unique Challenges
mRNA-seq	Focuses on messenger RNA (mRNA), typically through poly-A enrichment or rRNA depletion.	RNA degradation, incomplete cDNA synthesis, and rRNA contamination.
Total RNA-seq	Includes all RNA types (mRNA, rRNA, non-coding RNAs).	Biases in rRNA depletion have difficulty detecting low-abundance transcripts.
Small RNA-seq	Targets small RNAs (e.g., miRNAs, snRNAs).	Adapter contamination, difficulties in quantifying low-abundance small RNAs.

Solutions and Mitigation Strategies

Each RNA-seq application comes with its own set of unique challenges that can impact data quality. However, several targeted solutions can help mitigate these issues and improve the overall accuracy of results:

For mRNA-seq, using rRNA depletion or poly-A enrichment can effectively remove rRNA contamination and improve data quality. RNA integrity should also be checked using tools like the Bioanalyzer to ensure that degradation does not affect results.
In total RNA-seq, optimizing RNA extraction protocols and using advanced rRNA depletion techniques are essential to ensure that low-abundance transcripts are not overlooked. Additionally, using bioinformatics tools to correct rRNA bias during data analysis can improve the accuracy of the results.
For small RNA-seq, ensuring proper adapter ligation and removing contaminants during library preparation can help prevent adapter contamination. Additionally, careful quantification and using tools like miRDeep for analyzing small RNA data can mitigate challenges in quantifying low-abundance species.

Now that we’ve explored the unique challenges posed by different RNA-seq applications, let’s examine the best practices for ensuring RNA-seq quality control.

Best Practices for RNA-seq Quality Control

Ensuring high-quality RNA sequencing (RNA-seq) data is crucial for obtaining accurate, reliable, and reproducible results. Based on researchers’ experiences, several best practices have emerged that help optimize RNA-seq workflows.

Below are some key practices that have proven to be effective, along with real-world examples of how they’ve benefited researchers.

Perform Rigorous Quality Control (QC) at Every Stage: Implementing QC measures throughout the RNA-seq process helps detect and correct issues early. For example, a researcher noticed a high proportion of ambiguously aligned reads, suspecting rRNA contamination.

By reviewing the top expressed genes, they found rRNA contamination, which prompted them to adopt more efficient rRNA depletion techniques, ultimately improving their data quality.

Utilize Established QC Tools: Reliable QC tools like FastQC and MultiQC allow for comprehensive assessments of sequencing data quality.
Regularly Monitor RNA Quality and Sequencing Metrics: Consistently monitoring RNA quality and sequencing metrics helps identify issues such as RNA degradation, which can negatively impact downstream analysis.

One researcher observed that samples with lower A260/A230 ratios exhibited reduced RNA integrity, leading them to reassess their RNA extraction protocols to improve the quality of their samples. This proactive monitoring helped ensure the suitability of samples for RNA-seq.

Automating the QC Process to Streamline Workflows: Automation reduces human error and ensures continuous monitoring of RNA-seq quality throughout the process. A researcher integrated tools like RSeQC and FastQC into their automated pipeline, which allowed them to monitor data quality across multiple samples continuously.

This automation detected issues such as adapter contamination and uneven read distribution early in the process, enabling them to take prompt corrective actions and enhance the reliability of their results.

These best practices are essential for ensuring the reliability and accuracy of RNA-seq data. However, implementing them requires a combination of effective tools and expertise.

Why Choose Biostate AI?

Biostate AI simplifies RNA sequencing by offering affordable, high-quality total RNA sequencing services tailored to researchers’ needs. We ensure that you receive clean and reliable sequencing data, minimizing common issues like adapter contamination and low-quality bases that can compromise results.

Here’s how Biostate AI enhances your RNA-seq experience:

Expert Data Handling: Our sequencing process is designed to minimize contamination risks, enhance data quality, and ensure more reliable results at every stage.
Accurate Results: By implementing stringent trimming and quality control measures, Biostate AI ensures that your sequencing data is of the highest quality, making it ideal for accurate downstream analysis.
Flexible Sample Support: Whether you’re working with complex sample types such as FFPE tissue, blood, or others, Biostate AI optimizes the sequencing process to deliver accurate, reproducible results, regardless of sample complexity.
Cost-Effective Solutions: With services starting at just $80 per sample, Biostate AI provides an affordable solution for obtaining high-quality RNA sequencing data without compromising accuracy.

Our expert team is dedicated to providing you with clean, well-processed data, enabling researchers to generate meaningful insights efficiently and effectively, all while minimizing effort and cost.

Conclusion

Ensuring high-quality RNA sequencing data is essential for obtaining accurate, reproducible results. The effectiveness of RNA-seq largely depends on rigorous quality control (QC) at every stage, from RNA integrity checks to post-sequencing data analysis.

Implementing a multi-perspective QC approach—focusing on RNA quality, raw read data, alignment, and gene expression analysis—ensures that the data remains accurate and reliable throughout the pipeline.

By addressing contamination, degradation, and misalignment issues early on, researchers can optimize their results and gain more robust biological insights.

At Biostate AI, we offer reliable and cost-effective RNA sequencing services designed to meet the diverse needs of researchers. From handling complex sample types to ensuring clean and accurate sequencing data, we provide the expertise and tools necessary to guarantee high-quality results.

Whether you’re working with mRNA, lncRNA, miRNA, or piRNA from various sample types, Biostate AI ensures that your data is ready for meaningful analysis.

Ready to simplify your RNA sequencing workflow while maintaining top-tier data quality? Get a quote today and let Biostate AI deliver the reliable RNA sequencing services you need to propel your research forward.